arrow
A

Anubhav Mittal

Faculty of Medicine and Health
H指数:33
被引数:4,089

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification

绘制胰腺癌的蛋白质组学图谱:预后见解与亚型分层

2025-10-010
OA
ASO Visual Abstract: Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN)-Clinicopathological Features, Recurrence and Response to Adjuvant Chemotherapy
2024-07-150
PRE
Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN): Clinicopathological Features, Recurrence and Response to Adjuvant Chemotherapy

导管内乳头状黏液性肿瘤 (A-IPMN) 引起的腺癌前体上皮亚型: 临床病理特征,复发和对辅助化疗的反应

2024-07-032
OAAI
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study

导管内乳头状黏液性肿瘤引起的腺癌的辅助化疗: 多中心腺-IPMN研究

2024-04-253
OA
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study)
2023-10-248
PRE
A proteomic-based prognostic signature of pancreatic adenocarcinoma
2023-04-040
PRE
The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer

中性粒细胞与淋巴细胞比率 (NLR),血小板与淋巴细胞比率 (PLR) 和淋巴细胞与单核细胞比率 (LMR) 作为生物标志物在切除的胰腺癌中的预后和预测作用

2023-03-0221
OAAI